Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Immunoglobulin kappa variable 2D-26 (IGKV2D-26) is a human pseudogene belonging to the kappa light chain variable region gene family of immunoglobulins. It encodes the V (variable) domain of immunoglobulin light chains, which are essential for antigen recognition in functional immunoglobulins. However, IGKV2D-26 itself is annotated as a pseudogene, meaning it does not produce a functional protein. The immunoglobulin variable region genes, when functional, mediate antigen binding as part of the body's humoral immune response, but IGKV2D-26 does not encode a functional antibody chain and is not known to have therapeutic or biomarker relevance[1][2][5]. Clarification: IGKV2D-26 is a pseudogene—not a functional receptor, enzyme, transporter, or common therapeutic target. Its classification as a pseudogene means it does not encode a functional protein product and therefore is not druggable or directly linked to disease mechanisms, drug interactions, or safety concerns[1][2][5].
None
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Immunoglobulin kappa variable 2D-26 (IGKV2D-26).